ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008

NCI selects nanotech centers for funding.

October 14, 2005

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001